welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Celecoxib in a 12-Year-Old Boy with Familial Adenomatous Polyposis
source: International journal of clinical pharmacology and therapeutics
year: 2010
authors: Pérez-Segura P, Bodas A, Sereno M, Martínez-Amores B, Olivera H, Díaz S, López-Asenjo J A, Puente J, Maluenda C, Díaz-Rubio E
summary/abstract:Familial Adenomatous Polyposis (FAP) is an autosomal dominant disorder characterized by colonic polyps in early adult life. Children with this disease are at risk for colonic cancer, so prophylactic colectomy is the standard treatment to prevent this complication. Chemoprevention experience with NSAIDs in children is exceptional. This case report describes our experience with Celecoxib, a COX-2 inhibitor, in a 12-year-old boy.
organization: Hospital Clínico San Carlosread more full text source
expertly curated content related to this topic
-
Risk of Cancer and Secondary Proctectomy After Colectomy and Ileorectal Anastomosis in Familial Adenomatous Polyposi...PURPOSE : The aim of our retrospective s...
-
Nexavar Narrative: 7 Month Updatehttps://www.youtube.com/watch?v=4I3D66vr...
-
Evaluation of 28 Years of Surgical Treatment of Children and Young Adults with Familial Adenomatous PolyposisBACKGROUND : In this retrospective study...
-
Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) PatientsMalignant transformation of adenomas of ...
-
Global Quantitative Assessment of the Colorectal Polyp Burden in Familial Adenomatous Polyposis by Using a Web-based...BACKGROUND: Accurate measures of the to...
-
Familial Adenomatous Polyposis: Ileo-Anal Pouch versus Ileo-Rectal AnastomosisAIM : In this study we describe the pres...
-
Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysisObjective The benefits of pancreatic ...